How is Tanner scoring used to assess pubertal development in an adolescent or young adult female patient with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tanner Staging in MRKH Syndrome

Direct Answer

Tanner staging in females with MRKH syndrome is performed identically to the general population, assessing breast development (B1-B5) and pubic hair development (P1-P5), as these secondary sexual characteristics develop normally due to functional ovaries and normal hormonal axis. 1, 2

Understanding MRKH and Normal Pubertal Development

MRKH syndrome affects only the Müllerian structures (uterus and upper 2/3 of vagina) while leaving ovarian function completely intact. 3, 4 This means:

  • Patients have normal 46,XX karyotype 3, 5
  • Secondary sexual characteristics develop normally 2, 3, 5
  • Ovaries are functional and produce normal hormones 2, 5
  • External genitalia appear normal 2, 4

Tanner Staging Assessment

Breast Development (Tanner B Stages)

  • Assess breast development from B1 (prepubertal) through B5 (adult contour) 1
  • Breast development is the first sign of true puberty in females, not pubic hair 1
  • Normal breast development typically begins between ages 8-14 years 6
  • In MRKH patients, breast development proceeds normally as ovarian estrogen production is unaffected 2, 3

Pubic Hair Development (Tanner P Stages)

  • Assess pubic hair from P1 (prepubertal) through P5 (adult distribution) 7, 2
  • The case report documents a patient with MRKH at Tanner stage P5 & B4, demonstrating normal progression 2
  • Pubic hair before age 8 represents premature pubarche and requires separate evaluation 6

Clinical Application in MRKH

When to Perform Tanner Staging

  • Every 6 months until Tanner stage 5 is reached 7
  • At every clinical visit to monitor growth and development 7
  • During initial evaluation for primary amenorrhea, which is typically the presenting complaint 2, 3, 5

Key Diagnostic Distinction

The critical finding in MRKH is:

  • Normal Tanner staging progression (indicating functional ovaries and normal HPG axis) 2, 3
  • Combined with primary amenorrhea by age 16 years 6, 2
  • This combination distinguishes MRKH from ovarian insufficiency or other causes of delayed puberty 6, 3

Pitfalls to Avoid

Do not confuse isolated pubic or axillary hair (adrenarche) with true pubertal development—breast development (thelarche) is the first sign of HPG axis activation. 1

If a patient with suspected MRKH shows delayed or absent breast development, consider alternative diagnoses such as ovarian insufficiency and measure FSH and estradiol levels. 6

Primary amenorrhea with normal Tanner staging should prompt evaluation for anatomical causes like MRKH, while primary amenorrhea with delayed Tanner staging suggests hormonal causes. 6, 2

Monitoring Schedule

  • Document Tanner staging every 6 months during pubertal years 7
  • Include height, weight, and growth velocity measurements alongside Tanner staging 1
  • For prepubertal girls ≥11 years who fail to initiate puberty, obtain FSH and estradiol levels 6
  • No breast development by age 13 with elevated FSH warrants endocrinology consultation 6

References

Guideline

Management of Precocious Puberty in Girls

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Mayer-Rokitansky-Küster-Hauser syndrome as an interdisciplinary problem.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2020

Research

Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome.

Orphanet journal of rare diseases, 2007

Guideline

Puberty Onset and Progression Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.